GoodRx vs Ivy Rx
GoodRx costs $26 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Ivy Rx
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Ivy Rx →If you are choosing between GoodRx and Ivy Rx, the first difference is cost: GoodRx is $26 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. Ivy Rx leads our six-part score, 7.3 to 6.9.
GoodRx vs Ivy Rx price
GoodRx is the cheaper way in: $149 a month against $175 a month at Ivy Rx. That is $26 less each month (15% lower), or about $312 over a year of treatment.
Drug by drug: Tirzepatide is cheaper at Ivy Rx ($275 a month vs $299 a month).
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only Ivy Rx lists semaglutide.
On format, GoodRx prices brand-name pens, while Ivy Rx prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and Ivy Rx lists 50 states.
They overlap in 50 states.
Pricing
GoodRx
Ivy Rx
Range up to $197/mo
Range up to $297/mo
What each price covers
Ivy Rx's price also covers the clinician visit, the medication itself and shipping, which GoodRx does not claim.
GoodRx does not say what its price includes.
Ivy Rx is silent on lab work and coaching.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
GoodRx
Inclusions not disclosed.
Ivy Rx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Ivy Rx scores 7.3 and GoodRx 6.9 out of 10.
GoodRx is stronger on value (5.0 vs 3.0).
Ivy Rx is stronger on user experience (8.0 vs 5.0), trust & safety (7.5 vs 6.0) and support (7.0 vs 5.0).
Effectiveness and accessibility are within half a point.
GoodRx
6.9/10
Ivy Rx
7.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GoodRx nor Ivy Rx has an FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Ivy Rx |
|---|---|---|
| Starting Price | ✓$149/mo | $175/mo |
| Features | ✓6 features | 3 features |
| States Available | 50 | 50 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Ivy Rx
Ivy Rx is a telehealth seller running tiered compounded semaglutide and tirzepatide programs.
Read our full Ivy Rx review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Ivy Rx
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Ivy Rx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Ivy Rx wins this one, 7.3 to 6.9, above all for coverage in all 50 states, which most sellers will not confirm. GoodRx undercuts it by $26 a month, so if the monthly bill is what decides it, GoodRx is the pick. GoodRx fits better if oral orforglipron alongside the injectables is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Ivy Rx if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $175 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →GoodRx vs Ivy Rx: FAQ
Close alternatives to GoodRx and Ivy Rx
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- Ivy Rx vs DudeMeds
- Ivy Rx vs Curve
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.